Currently, the FTC has jurisdiction to review all hospital mergers, but it is prohibited from enforcing antitrust laws against any anticompetitive practices of nonprofit entities, which comprise more than 48 percent of all U.S. hospitals, according to the American Hospital Association.
“There is no question that hospital consolidation hurts patients by causing healthcare costs to jump and removing choice,” Ms. Jayapal said in a Dec. news release. “My bipartisan bill with Congresswoman Spartz would put in important guardrails to prevent corporations from putting profits over proper patient care without changing anything else about a hospital’s nonprofit status.”
Before the pandemic, a 2020 report from Medicare Payment Advisory Commission found that hospital mergers lead to higher healthcare prices for patients. In addition, 90 percent of hospital markets would be deemed highly concentrated by FTC standards, and in most markets, a single hospital system had more than a 50 percent market share of discharges.
“Hospital consolidation and lack of competition is a major factor driving unsustainable health care prices,” Ms. Spartz said. “More than one of eight Americans and one of six Hoosiers are in collections due to medical debt, which is unacceptable. Nonprofit hospital status should not be a loophole to avoid antitrust enforcement.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
